Cloning and nucleotide sequence analysis of a gene encoding an OXA- derived β-lactamase in Acinetobacter baumannii

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 12, 1997, Pages 2757-2759

  Vila, Jordi ^a   Navia, Margarita ^a   Ruiz, Joaquim ^a   Casals, Climent ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEPHALOSPORINASE;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; MOLECULAR CLONING; MUTATION; NONHUMAN; NOTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 0030777048     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.12.2757     Document Type: Note

References (19)

1. Ambler, R. P. 1980. The structure of β-lactamases. Philos. Trans. R. Soc. London (Biol.) 289:321-331.
2. Bergogne-Bèrèzin, E., M. L. Joly-Guillou, and J. F. Vieu. 1987. Epidemiology of nosocomial infections due to Acinetobacter baumannii. J. Hosp. Intect. 10:105-113.
3. Bergogne-Bèrèzin, E., and K. J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
4. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
5. Holland, S., and J. W. Dale. 1985. Immunological comparison between OXA-2 β-lactamase and those mediated by other R plasmids. Antimicrob. Agents Chemother. 27:989-991.
6. Levesque, C., and P. H. Roy. 1993. PCR analysis of integrons, p. 590-594. In D. H. Persing, T. F. Smith, F. C. Tenover, and T. J. White (ed.), Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C.
7. Matthew, M., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
8. National Committee for Clinical Laboratory Standards. 1990. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. Approved standard M7-A2. National Committee for Clinical Laboratory Standard, Villanova, Pa.
9. Sanschagrin, F., F. Couture, and R. C. Levesque. 1995. Primary structure of OXA-3 and phylogeny of oxacillin-hydrolyzing class D β-lactamases. Antimicrob. Agents Chemother. 39:887-893.
10. Sato, K., and T. Nakae. 1991. Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. J. Antimicrob. Chemother. 28:35-45.
11. Seifert, H., R. Baginski, A. Schulze, and G. Pulverer. 1993. Antimicrobial susceptibility of Acinetobacter species. Antimicrob. Agents Chemother. 37:750-753.
12. Shi, Z. Y., P. Liu, Y. J. Lau, Y. H. Lin, B.-S. Hu, and J.-M. Shir. 1996. Antimicrobial susceptibility of clinical isolates of Acinetobacter baumannii. Diagn. Microbiol. Infect. Dis. 24:81-85.
13. Siegman-Ingra, Y., S. Bar-Yosef, A. Gorea, and J. Avram. 1993. Nosocomial Acinetobacter meningitis secondary to invasive procedures: report of 25 cases and review. Clin. Infect. Dis. 17:843-849.
14. Tilley, P. A. G., and F. J. Roberts. 1994. Bacteremia with Acinetobacter species: risk factors and prognosis in different clinical settings. Clin. Infect. Dis. 18:896-900.
15. Traub, W. H., and M. Spohr. 1989. Antimicrobial drug susceptibility of clinical isolates of Acinetobacter species (A. baumannii, A. haemolyticus, genospecies 3, and genospecies 6). Antimicrob. Agents Chemother. 33:1617-1619.
16. Vila, J., M. Almela, and M. T. Jimenez de Anta. 1989. Laboratory investigation of hospital outbreak caused by two different multiresistant Acinetobacter calcoaceticus subsp. anitratus strains. J. Clin. Microbiol. 27:1086-1089.
17. Vila, J., A. Marcos, F. Marco, F. Abdalla, Y. Vergara, R. Reig, R. Gomez-Lus, and M. T. Jimenez de Anta. 1993. In vitro antimicrobial production of β-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 37:138-141.
18. Vila, J., A. Marcos, T. Llovet, P. Coll, and M. T. Jimenez de Anta. 1994. A comparative study of ribotyping and arbitrarily primed polymerase chain reaction for investigation of hospital outbreaks. J. Med. Microbiol. 41:244-249.
19. Vila, J., A. Marcos, and M. T. Jimenez de Anta. 1996. A comparative study of different PCR-based DNA fingerprinting techniques for typing of the Acinetobacter calcoaceticus-A. baumannii complex. J. Med. Microbiol. 44:482-489.